Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
manufacturing plant
Manufacturing
FDA rebukes troubled Eugia production site with a warning letter
Aurobindo’s Eugia unit suffered a blow from the FDA after the U.S. regulatory agency issued a warning letter in the wake of previous inspections.
Joseph Keenan
Aug 19, 2024 8:10am
Vivint Pharma to spend $48M to build injectables plant in India
Aug 9, 2024 8:45am
CDMO Brassica blasted in 4-observation FDA warning letter
Jul 24, 2024 9:25am
Novo scoops up 200 acres for a potential new production plant
Jul 23, 2024 10:35am
Kyowa Kirin to build $530M biologics plant in North Carolina
Jun 10, 2024 10:47am
CDMO Vetter plans new sites in Illinois, Germany
Jun 6, 2024 2:39pm
